BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 36031641)

  • 1. Signaling pathways in obesity: mechanisms and therapeutic interventions.
    Wen X; Zhang B; Wu B; Xiao H; Li Z; Li R; Xu X; Li T
    Signal Transduct Target Ther; 2022 Aug; 7(1):298. PubMed ID: 36031641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic correlation of molecular pathways in obesity-mediated stroke pathogenesis.
    Khan H; Tiwari C; Kalra P; Vyas D; Grewal AK; Singh TG
    Pharmacol Rep; 2024 Jun; 76(3):463-474. PubMed ID: 38632185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
    Avenell A; Broom J; Brown TJ; Poobalan A; Aucott L; Stearns SC; Smith WC; Jung RT; Campbell MK; Grant AM
    Health Technol Assess; 2004 May; 8(21):iii-iv, 1-182. PubMed ID: 15147610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential to Fight Obesity with Adipogenesis Modulating Compounds.
    Zhao J; Zhou A; Qi W
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.
    Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.
    Grams J; Garvey WT
    Curr Obes Rep; 2015 Jun; 4(2):287-302. PubMed ID: 26627223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent fasting interventions for the treatment of overweight and obesity in adults aged 18 years and over: a systematic review protocol.
    Jane L; Atkinson G; Jaime V; Hamilton S; Waller G; Harrison S
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):60-8. PubMed ID: 26571283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes.
    Finer N
    Diabetes Obes Metab; 2022 Feb; 24 Suppl 2():44-54. PubMed ID: 34622555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment modalities of obesity: what fits whom?
    Hainer V; Toplak H; Mitrakou A
    Diabetes Care; 2008 Feb; 31 Suppl 2():S269-77. PubMed ID: 18227496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic roles of G protein-coupled receptor signaling in obesity and type 2 diabetes.
    Barella LF; Jain S; Kimura T; Pydi SP
    FEBS J; 2021 Apr; 288(8):2622-2644. PubMed ID: 33682344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic signals and innate immune activation in obesity and exercise.
    Ringseis R; Eder K; Mooren FC; Krüger K
    Exerc Immunol Rev; 2015; 21():58-68. PubMed ID: 25825956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of obesity and lifestyle interventions in the prevention and management of type 2 diabetes.
    Davis N; Forges B; Wylie-Rosett J
    Minerva Med; 2009 Jun; 100(3):221-8. PubMed ID: 19571786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Diabetes and Cardiovascular Disease in Obesity.
    La Sala L; Pontiroli AE
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipogenesis and therapeutic potentials of antiobesogenic phytochemicals: Insights from preclinical studies.
    Murugan DD; Balan D; Wong PF
    Phytother Res; 2021 Nov; 35(11):5936-5960. PubMed ID: 34219306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body composition, inflammation and thermogenesis in pathways to obesity and the metabolic syndrome: an overview.
    Dulloo AG; Montani JP
    Obes Rev; 2012 Dec; 13 Suppl 2():1-5. PubMed ID: 23107254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and type 2 diabetes.
    Maggio CA; Pi-Sunyer FX
    Endocrinol Metab Clin North Am; 2003 Dec; 32(4):805-22, viii. PubMed ID: 14711063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the pathophysiologic pathways that underlie obesity and options for treatment.
    Kumar RB; Srivastava G; Reid TJ; Aronne LJ
    Expert Rev Endocrinol Metab; 2021 Nov; 16(6):321-338. PubMed ID: 34904501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How effective are traditional dietary and exercise interventions for weight loss?
    Miller WC
    Med Sci Sports Exerc; 1999 Aug; 31(8):1129-34. PubMed ID: 10449014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.